Russia says its second COVID-19 vaccine is 100pc effective

Russia's consumer health watchdog Rospotrebnadzor on Tuesday said Russia's second vaccine against COVID-19 is 100% effective based on the results of clinical trials, the TASS news agency reported.

>>Reuters
Published : 19 Jan 2021, 12:19 PM
Updated : 19 Jan 2021, 12:19 PM

Russia began mass trials of EpiVacCorona, which is being developed by Siberia's Vector Institute, in November.

Moscow has said its other approved COVID-19 vaccine, Sputnik V, is 92% effective at protecting people from COVID-19 according to interim results.